Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2918160 | Heart, Lung and Circulation | 2012 | 5 Pages |
Abstract
In selected high-risk patients, trans-catheter valve implantation is an emerging therapy for a degenerated bioprosthesis in need of repeated valve replacement. During the last two years, valve-in-valve implantations have mainly been performed in the aortic position and only rarely in the mitral position. Here we describe for the first time the case of a 62Â year-old female with severe mitral regurgitation of a degenerated Carpentier Edwards bioprosthesis treated by transjugular, transseptal implantation of a SAPIEN-XT valve. In conclusion this case, together with previous reports, show the feasibility and safety of percutaneous valve-in-valve implantations to treat a degenerated bioprosthesis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ulrich MD, Christian MD, Cord MD, Karl-Heinz MD,